<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">1848</item><item key="factors"><item><item key="GSE4097GSM93712"><item key="Phenotype">wild_type</item><item key="Compound">doxycycline</item></item></item><item><item key="GSE4097GSM93712"><item key="Phenotype">wild_type</item><item key="Compound">doxycycline</item></item></item><item><item key="GSE4097GSM93711"><item key="Phenotype">induced AICD expression</item><item key="Compound">none</item></item></item><item><item key="GSE4097GSM93711"><item key="Phenotype">induced AICD expression</item><item key="Compound">none</item></item></item><item><item key="GSE4097GSM93715"><item key="Phenotype">induced AICD and Fe65 expression</item><item key="Compound">none</item></item></item><item><item key="GSE4097GSM93712"><item key="Phenotype">wild_type</item><item key="Compound">doxycycline</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">3</item><item key="summary_wrapped">The amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer&#8217;s disease (AD). Processing of APP by &#946;- and...</item><item key="pubmed_id">17093061</item><item key="geo_gse_id">E-GEOD-4097</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>actin</item><item>actin cytoskeleton</item><item>cell</item><item>central</item><item>cytoskeleton</item><item>disease</item><item>neural cell</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-of-human-shep-sf-cells-exp</item><item key="geo_id_plat">E-GEOD-4097_A-AFFY-33</item><item key="name">Transcription profiling of human SHEP-SF cells expressing AICD and Fe65</item><item key="created">Jun.20, 2014</item><item key="summary">The amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer&#8217;s disease (AD). Processing of APP by &#946;- and &#947;-secretase activities results in the production of &#223;-amyloid (A&#223;), the main constituent of Alzheimer plaques, but also in the generation of the APP intracellular domain (AICD). Recently, it has been demonstrated that AICD has transactivation potential, however, the targets of AICD dependent gene regulation and hence the physiological role of AICD remain largely unknown. In this work we analysed transcriptome changes during AICD dependent gene regulation using a human neural cell culture system inducible for expression of AICD, its co-activator Fe65, or the combination of both. Induction of AICD was associated with increased expression of genes with known function in the organization and dynamics of the actin cytoskeleton as well as genes involved in the regulation of apoptosis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-4097</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-4097/samples/</item></data></biogps>
